The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders

[1]  G. van Thiel,et al.  Series: Pragmatic trials and real world evidence: Paper 1. Introduction. , 2017, Journal of clinical epidemiology.

[2]  Jorie M. Butler,et al.  Veterans Healthcare Administration providers’ attitudes and perceptions regarding pragmatic trials embedded at the point of care , 2014, Clinical Trials.

[3]  M. Zwarenstein,et al.  PRECIS-2 helps researchers design more applicable RCTs while CONSORT Extension for Pragmatic Trials helps knowledge users decide whether to apply them. , 2017, Journal of clinical epidemiology.

[4]  M. Zwarenstein,et al.  What kind of randomized trials do we need? , 2009, Canadian Medical Association Journal.

[5]  Steven Joffe,et al.  Attitudes Toward Risk and Informed Consent for Research on Medical Practices , 2015, Annals of Internal Medicine.

[6]  A. Carcas,et al.  Public preferences on written informed consent for low‐risk pragmatic clinical trials in Spain , 2017, British journal of clinical pharmacology.

[7]  S. Kalkman,et al.  Pragmatic randomized trials in drug development pose new ethical questions: a systematic review. , 2015, Drug discovery today.

[8]  Gila Neta,et al.  Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory , 2016, Trials.

[9]  David Moher,et al.  Increasing value and reducing waste in biomedical research: who's listening? , 2016, The Lancet.

[10]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[11]  Scott Y. H. Kim.  Ethical issues in pragmatic trials of “standard‐of‐care” interventions in learning health care systems , 2018, Learning health systems.

[12]  Joseph E. Andrews,et al.  Harms, benefits, and the nature of interventions in pragmatic clinical trials , 2015, Clinical trials.

[13]  Rieke van der Graaf,et al.  International Ethical Guidelines for Health-related Research involving Humans , 2017 .

[14]  C. Feudtner,et al.  SUPPORT and the Ethics of Study Implementation: Lessons for Comparative Effectiveness Research from the Trial of Oxygen Therapy for Premature Babies. , 2015, The Hastings Center report.

[15]  D. Grobbee,et al.  PRECIS-2 in perspective: what is next for pragmatic trials? , 2017, Journal of clinical epidemiology.

[16]  Nikolaos A. Patsopoulos,et al.  A pragmatic view on pragmatic trials , 2011, Dialogues in clinical neuroscience.

[17]  P. Donnan,et al.  PRECIS-2: a tool to improve the applicability of randomised controlled trials , 2013, Trials.

[18]  D. Wendler,et al.  A Framework for Risk-Benefit Evaluations in Biomedical Research , 2011, Kennedy Institute of Ethics journal.

[19]  J. Grimshaw,et al.  The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials , 2012, PLoS medicine.

[20]  Jeremy Sugarman,et al.  Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems , 2015, Clinical trials.

[21]  Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation , 2018, BMC medical ethics.

[22]  Bridget C. O’Brien,et al.  Standards for Reporting Qualitative Research: A Synthesis of Recommendations , 2014, Academic medicine : journal of the Association of American Medical Colleges.

[23]  P. Donnan,et al.  The PRECIS-2 tool has good interrater reliability and modest discriminant validity. , 2017, Journal of clinical epidemiology.

[24]  J. Grimshaw,et al.  An Ethical Analysis of the SUPPORT Trial: Addressing Challenges Posed by a Pragmatic Comparative Effectiveness Randomized Controlled Trial , 2018, Kennedy Institute of Ethics journal.

[25]  D. Hunter.  Can the Regulatory Response to SUPPORT be Supported? , 2013, The American journal of bioethics : AJOB.

[26]  D. Blockley.  Making , 2020, The Hidden History of the Smock Frock.

[27]  Jonathan McCall,et al.  Use of altered informed consent in pragmatic clinical research , 2015, Clinical trials.

[28]  H. Bastian,et al.  Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? , 2010, PLoS medicine.

[29]  R. Bellomo,et al.  Why we must cluster and cross over. , 2013, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[30]  B. Wilfond,et al.  The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials , 2015, Clinical trials.

[31]  H. Ten Have,et al.  CIOMS , 2021, Dictionary of Global Bioethics.

[32]  G. Persad,et al.  Differential payment to research participants in the same study: an ethical analysis , 2019, Journal of Medical Ethics.

[33]  Sarah M. Greene,et al.  Oversight on the borderline: Quality improvement and pragmatic research , 2015, Clinical trials.

[34]  S. Kalkman,et al.  Participant eligibility , recruitment and retention in pragmatic trials 1 2 , 2017 .

[35]  J. V. Delden,et al.  How the CIOMS guidelines contribute to fair inclusion of pregnant women in research. , 2019 .

[36]  Jeremy Sugarman,et al.  Exploring the ethical and regulatory issues in pragmatic clinical trials , 2015, Clinical trials.

[37]  J. Grimshaw,et al.  Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol , 2018, BMC Medical Ethics.

[38]  S. Bandewar.  CIOMS 2016. , 2017, Indian journal of medical ethics.

[39]  J. Norrie,et al.  Pragmatic Trials. , 2016, The New England journal of medicine.

[40]  S. Kalkman,et al.  Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs , 2016, Trials.

[41]  Pam Carter,et al.  The social licence for research: why care.data ran into trouble , 2015, Journal of Medical Ethics.

[42]  Shaun Treweek,et al.  Making trials matter: pragmatic and explanatory trials and the problem of applicability , 2009, Trials.

[43]  E. Emanuel,et al.  Evaluating the risks of clinical research. , 2010, JAMA.

[44]  Merrick Zwarenstein,et al.  The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research , 2012, Clinical trials.

[45]  Scott Y. H. Kim,et al.  A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials , 2016, Clinical trials.

[46]  P. Pronovost,et al.  The Views of Quality Improvement Professionals and Comparative Effectiveness Researchers on Ethics, IRBs, and Oversight , 2015, Journal of empirical research on human research ethics : JERHRE.

[47]  D. Grobbee,et al.  Pragmatic trials and real world evidence – an introduction to the series , 2017 .

[48]  R J Lilford,et al.  The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting , 2015, BMJ : British Medical Journal.

[49]  Joakim Ramsberg,et al.  Opportunities and barriers for pragmatic embedded trials: Triumphs and tribulations , 2017, Learning health systems.

[50]  J. Wyatt,et al.  Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide , 2014, BMJ : British Medical Journal.

[51]  A. Carcas,et al.  Patients’ beliefs regarding informed consent for low-risk pragmatic trials , 2017, BMC Medical Research Methodology.

[52]  J. Lellouch,et al.  Explanatory and pragmatic attitudes in therapeutical trials. , 1967, Journal of chronic diseases.

[53]  A. Bryman.  Social Research Methods , 2001 .

[54]  C. Forrest,et al.  Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol , 2018, Trials.

[55]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[56]  S. Joffe,et al.  Gatekeepers for pragmatic clinical trials , 2015, Clinical trials.

[57]  David Moher,et al.  Reducing waste from incomplete or unusable reports of biomedical research , 2014, The Lancet.

[58]  J. Merz,et al.  What gives them the right? Legal privilege and waivers of consent for research , 2018, Clinical trials.

[59]  Stephanie R. Morain,et al.  Alternative consent models for comparative effectiveness studies: Views of patients from two institutions , 2016 .

[60]  P. Glasziou,et al.  What’s the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed , 2017, BMC Medical Research Methodology.

[61]  S. Kalkman,et al.  Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences. , 2017, Journal of clinical epidemiology.

[62]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[63]  P. Appelbaum,et al.  Clinical Concerns and the Validity of Clinical Trials , 2013 .

[64]  B. Wilfond.  Quality Improvement Ethics: Lessons From the SUPPORT Study , 2013, The American journal of bioethics : AJOB.

[65]  Steven N Goodman,et al.  An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. , 2013, The Hastings Center report.

[66]  Ellen K. Feder,et al.  The OHRP and SUPPORT--another view. , 2013, The New England journal of medicine.

[67]  Kathleen M. Brelsford,et al.  Physicians' perspectives regarding pragmatic clinical trials. , 2016, Journal of comparative effectiveness research.

[68]  N. Kass,et al.  Stakeholders' Views of Alternatives to Prospective Informed Consent for Minimal-Risk Pragmatic Comparative Effectiveness Trials , 2015, Journal of Law, Medicine & Ethics.